An interventional study of Testing of digital application in Medication Adherence, sponsored by NHS Highland Research, Development and Innovation Organisation. Completed at 1 site in United Kingdom. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by NHS Highland Research, Development and Innovation Organisation · Not applicable, Interventional, and Supportive care
This project aims to examine whether the MedTracks app is useful and easy to use for a cohort of adults taking two or more oral medications. It will also aim to indicate if use of the app changes attitudes and improves self-reported medication adherence. Qualitative interviews will be conducted with a sub-set of participants to examine issues in greater depth.
Medication adherence in chronic disease remains a significant global challenge, contributing to poorer health outcomes and increased healthcare costs. Although efforts have been made to improve adherence, non-adherence continues to be a major issue, particularly for people managing long-term conditions rather than short-term illnesses.
Research suggests that improving medication adherence can have substantial benefits, but there is no single solution that completely resolves the problem. Reasons for non-adherence can be broadly divided into intentional and unintentional factors. One of the most common unintentional reasons is simply forgetting to take medication, highlighting the potential value of reminder-based interventions.
While face-to-face approaches have been effective in improving adherence, digital technologies are increasingly being explored as accessible and scalable alternatives. Smartphone ownership is now widespread, providing opportunities for mobile health applications that support medication management. Evidence indicates that electronic reminders, including text messages and app-based notifications, can improve adherence and are often associated with high levels of user satisfaction.
Developing long-term medication-taking habits is an important aspect of adherence, and personalised approaches may be particularly effective. Technology can help support these approaches by tailoring reminders and routines to individual users. Research into music and memory suggests that music can have a strong and lasting connection to memory, even in people experiencing cognitive decline.
The MedTracks app aims to use this principle by incorporating user-selected music into medication reminders. By using music that has personal significance for each individual, the app seeks to create a more engaging and memorable reminder system. This study therefore aims to evaluate the usability and usefulness of the MedTracks app and assess whether it can improve self-reported medication adherence. Given the ongoing challenges associated with medication adherence, evaluating innovative technological solutions such as MedTracks remains an important area of research.
937 studies on the registry are indexed under Medication Adherence; 159 are open to participants now.
This study's enrollment of 31 is below the median of 120 across 768 interventional studies indexed under Medication Adherence.
Browse Medication Adherence studies →NHS Highland Research, Development and Innovation Organisation is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
2017) or alternatively iPhone with iOS 12.0 or higher (mid 2018). 6) Willing for the MedTracks app to be 'active' on the smartphone device for the duration of the Test Phase, including active reliable internet connection.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Testing of the MedTracks digital application
Other: Testing of digital application
Testing of the MedTracks digital application
System Usability Scale (SUS) self-reported questionnaire. A questionnaire to appraise hardware and software. The score is between 0 to 100 with a score of >68 being above average and <68 worse than average. A higher score means better usability.
Time frame: At 28 days post consent
Medication Adherence Report Score (MARS-10) validated questionnaire. Scores range from 10 to 50, with a higher score indicating better adherence to medication.
Time frame: At consent and at 28 days post consent.
Assess user experience and attitudes to MedTracks App use by means of semi-structured qualitative interviews
Time frame: Up to 4 months
Plan to share: No
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NHS Highland Research, Development and Innovation Organisation